Developing vaccines for various fungal infections
TASK V31: PROCESS DEVELOPMENT FOR PANFUNGAL VACCINES
This study is working on new vaccines to help protect people from serious fungal infections, especially those that could come from bioterrorism or new diseases, so that everyone can have better ways to stay healthy and safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-10888432 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new vaccines aimed at preventing fungal infections, particularly those that may arise from bioterrorism or emerging diseases. The project involves careful planning and assessment of vaccine development, ensuring that the manufacturing processes meet strict regulatory standards. Patients may benefit from the development of these vaccines through improved prevention strategies against serious infections. The research includes conducting clinical studies and toxicology assessments to ensure safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for fungal infections, such as those with compromised immune systems or underlying health conditions.
Not a fit: Patients who are not at risk for fungal infections or those who do not meet the criteria for vaccine trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of serious fungal infections.
How similar studies have performed: Other research has shown promise in developing vaccines for infectious diseases, indicating that this approach has potential for success.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.